{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:51:57Z","timestamp":1794610317638,"version":"4.9.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12602-025-10784-z","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:48:28Z","timestamp":1759294108000},"page":"3633-3647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Phage-Microbiota Interactions in the Gut: Implications for Health and Therapeutic Strategies"],"prefix":"10.1007","volume":"18","author":[{"given":"Ramtin","family":"Naderian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Alibabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Paraandavaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmida","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-678X","authenticated-orcid":false,"given":"Majid","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"10","key":"10784_CR1","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/pharmaceutics15102416","volume":"15","author":"SC Emencheta","year":"2023","unstructured":"Emencheta SC et al (2023) The role of bacteriophages in the gut microbiota: implications for human health. Pharmaceutics 15(10):2416","journal-title":"Pharmaceutics"},{"key":"10784_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.897926","author":"Z Zhu","year":"2022","unstructured":"Zhu Z et al (2022) Olanzapine-induced lipid disturbances: a potential mechanism through the gut microbiota-brain axis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.897926","journal-title":"Front Pharmacol"},{"issue":"4","key":"10784_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70048","volume":"4","author":"C Wang","year":"2025","unstructured":"Wang C et al (2025) Gut microbiota-derived butyric acid regulates calcific aortic valve disease pathogenesis by modulating GAPDH lactylation and butyrylation. Imeta 4(4):e70048","journal-title":"Imeta"},{"key":"10784_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00784","volume":"10","author":"TD Sutton","year":"2019","unstructured":"Sutton TD, Hill C (2019) Gut bacteriophage: current understanding and challenges. Front Endocrinol 10:490764","journal-title":"Front Endocrinol"},{"key":"10784_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1379382","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu X et al (2024) Gut phageome: challenges in research and impact on human microbiota. Front Microbiol 15:1379382","journal-title":"Front Microbiol"},{"key":"10784_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/v10070386","author":"J Callanan","year":"2018","unstructured":"Callanan J et al (2018) RNA phage biology in a metagenomic era. Viruses. https:\/\/doi.org\/10.3390\/v10070386","journal-title":"Viruses"},{"issue":"1","key":"10784_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2113717","volume":"14","author":"H Shuwen","year":"2022","unstructured":"Shuwen H, Kefeng D (2022) Intestinal phages interact with bacteria and are involved in human diseases. Gut Microbes 14(1):2113717","journal-title":"Gut Microbes"},{"key":"10784_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1166022","volume":"14","author":"F Chen","year":"2023","unstructured":"Chen F et al (2023) Effects of Litsea cubeba essential oil on growth performance, blood antioxidation, immune function, apparent digestibility of nutrients, and fecal microflora of pigs. Front Pharmacol 14:1166022","journal-title":"Front Pharmacol"},{"key":"10784_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom15010093","author":"H Tahmasebi","year":"2025","unstructured":"Tahmasebi H et al (2025) From cure to crisis: understanding the evolution of antibiotic-resistant bacteria in human microbiota. Biomolecules. https:\/\/doi.org\/10.3390\/biom15010093","journal-title":"Biomolecules"},{"issue":"2","key":"10784_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41385-019-0250-5","volume":"13","author":"R Sausset","year":"2020","unstructured":"Sausset R et al (2020) New insights into intestinal phages. Mucosal Immunol 13(2):205\u2013215","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10784_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41423-020-00532-4","volume":"18","author":"S Federici","year":"2021","unstructured":"Federici S, Nobs SP, Elinav E (2021) Phages and their potential to modulate the microbiome and immunity. Cell Mol Immunol 18(4):889\u2013904","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10784_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2309684","volume":"16","author":"Z Pei","year":"2024","unstructured":"Pei Z et al (2024) A universe of human gut-derived bacterial prophages: unveiling the hidden viral players in intestinal microecology. Gut Microbes 16(1):2309684","journal-title":"Gut Microbes"},{"issue":"3","key":"10784_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/v17030390","volume":"17","author":"M Eslami","year":"2025","unstructured":"Eslami M et al (2025) Deciphering host\u2013virus interactions and advancing therapeutics for chronic viral infection. Viruses 17(3):390","journal-title":"Viruses"},{"issue":"10","key":"10784_CR14","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/microorganisms11102454","volume":"11","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Gut phageome\u2014an insight into the role and impact of gut microbiome and their correlation with mammal health and diseases. Microorganisms 11(10):2454","journal-title":"Microorganisms"},{"key":"10784_CR15","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1038\/npjbiofilms.2016.10","volume":"2","author":"CB Silveira","year":"2016","unstructured":"Silveira CB, Rohwer FL (2016) Piggyback-the-winner in host-associated microbial communities. NPJ Biofilms Microbiomes 2:16010","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10784_CR16","doi-asserted-by":"publisher","first-page":"1320345","DOI":"10.3389\/fmicb.2023.1320345","volume":"14","author":"M Gli\u017aniewicz","year":"2024","unstructured":"Gli\u017aniewicz M et al (2024) Advances in bacteriophage-mediated strategies for combating polymicrobial biofilms. Front Microbiol 14:1320345","journal-title":"Front Microbiol"},{"key":"10784_CR17","doi-asserted-by":"publisher","first-page":"105973","DOI":"10.1016\/j.msard.2024.105973","volume":"92","author":"A Naseri","year":"2024","unstructured":"Naseri A et al (2024) 12. Sleep quality is not a predictor of information process speed in multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 92:105973","journal-title":"Mult Scler Relat Disord"},{"key":"10784_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105530","volume":"85","author":"S Sanaie","year":"2024","unstructured":"Sanaie S et al (2024) Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis. Mult Scler Relat Disord 85:105530","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10784_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-025-00789-x","volume":"11","author":"L Li","year":"2025","unstructured":"Li L et al (2025) A decrease in Flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders. Cell Discov 11(1):25","journal-title":"Cell Discov"},{"issue":"1","key":"10784_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00284-022-03112-z","volume":"80","author":"S Sedighi","year":"2023","unstructured":"Sedighi S et al (2023) Comprehensive investigations relationship between viral infections and multiple sclerosis pathogenesis. Curr Microbiol 80(1):15","journal-title":"Curr Microbiol"},{"key":"10784_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jare.2022.09.012","volume":"49","author":"F Chen","year":"2023","unstructured":"Chen F et al (2023) Meta-analysis of fecal viromes demonstrates high diagnostic potential of the gut viral signatures for colorectal cancer and adenoma risk assessment. J Adv Res 49:103\u2013114","journal-title":"J Adv Res"},{"issue":"8","key":"10784_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105221","volume":"9","author":"V Dinakaran","year":"2014","unstructured":"Dinakaran V et al (2014) Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation. PLoS ONE 9(8):e105221","journal-title":"PLoS ONE"},{"key":"10784_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.901559","volume":"13","author":"G Tong","year":"2022","unstructured":"Tong G et al (2022) Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway. Front Pharmacol 13:901559","journal-title":"Front Pharmacol"},{"issue":"4","key":"10784_CR24","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s12602-025-10513-6","volume":"17","author":"F Jamali","year":"2025","unstructured":"Jamali F et al (2025) Exploring innovative approaches for managing spinal cord injury: a comprehensive review of promising probiotics and postbiotics. Probiotics Antimicrob Proteins 17(4):2112\u20132132","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"26","key":"10784_CR25","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.1073\/pnas.1305923110","volume":"110","author":"JJ Barr","year":"2013","unstructured":"Barr JJ et al (2013) Bacteriophage adhering to mucus provide a non\u2013host-derived immunity. Proc Natl Acad Sci U S A 110(26):10771\u201310776","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10784_CR26","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1007\/s00253-014-5643-5","volume":"98","author":"S Kaur","year":"2014","unstructured":"Kaur S, Harjai K, Chhibber S (2014) Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages. Appl Microbiol Biotechnol 98:4653\u20134661","journal-title":"Appl Microbiol Biotechnol"},{"issue":"10","key":"10784_CR27","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","volume":"31","author":"K Champagne-Jorgensen","year":"2023","unstructured":"Champagne-Jorgensen K et al (2023) Immunogenicity of bacteriophages. Trends Microbiol 31(10):1058\u20131071","journal-title":"Trends Microbiol"},{"issue":"3","key":"10784_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451543","volume":"55","author":"HT Le","year":"2025","unstructured":"Le HT et al (2025) Differences in phage recognition and immunogenicity contribute to divergent human immune responses to Escherichia coli and Klebsiella pneumoniae phages. Eur J Immunol 55(3):e202451543","journal-title":"Eur J Immunol"},{"issue":"2","key":"10784_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","volume":"25","author":"L Gogokhia","year":"2019","unstructured":"Gogokhia L et al (2019) Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microbe 25(2):285-299.e8","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10784_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.23736\/S2724-6507.22.03752-6","volume":"47","author":"N Kobyliak","year":"2022","unstructured":"Kobyliak N et al (2022) Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. Minerva Endocrinol 47(2):242\u2013252","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"10784_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","volume":"160","author":"JM Norman","year":"2015","unstructured":"Norman JM et al (2015) Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160(3):447\u2013460","journal-title":"Cell"},{"issue":"12","key":"10784_CR32","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41590-019-0513-z","volume":"20","author":"L Liu","year":"2019","unstructured":"Liu L et al (2019) Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling. Nat Immunol 20(12):1681\u20131691","journal-title":"Nat Immunol"},{"issue":"70","key":"10784_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn6660","volume":"7","author":"F Adiliaghdam","year":"2022","unstructured":"Adiliaghdam F et al (2022) Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation. Sci Immunol 7(70):eabn6660","journal-title":"Sci Immunol"},{"issue":"2","key":"10784_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00262-017-2076-x","volume":"67","author":"P Murgas","year":"2018","unstructured":"Murgas P et al (2018) A filamentous bacteriophage targeted to carcinoembryonic antigen induces tumor regression in mouse models of colorectal cancer. Cancer Immunol Immunother 67(2):183\u2013193","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10784_CR35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","volume":"25","author":"BB Hsu","year":"2019","unstructured":"Hsu BB et al (2019) Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model. Cell Host Microbe 25(6):803-814.e5","journal-title":"Cell Host Microbe"},{"key":"10784_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1398652","author":"Y Li","year":"2024","unstructured":"Li Y et al (2024) Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1398652","journal-title":"Front Immunol"},{"issue":"13-s","key":"10784_CR37","volume":"91","author":"Z Naureen","year":"2020","unstructured":"Naureen Z et al (2020) Bacteriophages presence in nature and their role in the natural selection of bacterial populations. Acta Biomed 91(13-s):e2020024","journal-title":"Acta Biomed"},{"key":"10784_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","volume":"4","author":"SA Sarker","year":"2016","unstructured":"Sarker SA et al (2016) Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine 4:124\u2013137","journal-title":"EBioMedicine"},{"issue":"7","key":"10784_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrmicro.2017.30","volume":"15","author":"MK Mirzaei","year":"2017","unstructured":"Mirzaei MK, Maurice CF (2017) M\u00e9nage \u00e0 trois in the human gut: interactions between host, bacteria and phages. Nat Rev Microbiol 15(7):397\u2013408","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10784_CR40","first-page":"5","volume":"28","author":"N Nguyen","year":"2019","unstructured":"Nguyen N et al (2019) Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev 28(5):5","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10784_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.chom.2019.01.018","volume":"25","author":"L De Sordi","year":"2019","unstructured":"De Sordi L, Louren\u00e7o M, Debarbieux L (2019) The battle within: interactions of bacteriophages and bacteria in the gastrointestinal tract. Cell Host Microbe 25(2):210\u2013218","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10784_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2019.01.017","volume":"25","author":"AN Shkoporov","year":"2019","unstructured":"Shkoporov AN, Hill C (2019) Bacteriophages of the human gut: the \u201cknown unknown\u201d of the microbiome. Cell Host Microbe 25(2):195\u2013209","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10784_CR43","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3390\/microorganisms11051181","volume":"11","author":"L Chen","year":"2023","unstructured":"Chen L, Hou X, Chu H (2023) The novel role of phage particles in chronic liver diseases. Microorganisms 11(5):1181","journal-title":"Microorganisms"},{"key":"10784_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104113","author":"Z Cao","year":"2022","unstructured":"Cao Z et al (2022) The gut virome: a new microbiome component in health and disease. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104113","journal-title":"EBioMedicine"},{"issue":"2","key":"10784_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4161\/bact.1.2.14590","volume":"1","author":"C Loc-Carrillo","year":"2011","unstructured":"Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1(2):111\u2013114","journal-title":"Bacteriophage"},{"issue":"5","key":"10784_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.chom.2020.08.005","volume":"28","author":"T Zuo","year":"2020","unstructured":"Zuo T et al (2020) Human-gut-DNA virome variations across geography, ethnicity, and urbanization. Cell Host Microbe 28(5):741\u2013751","journal-title":"Cell Host Microbe"},{"key":"10784_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15102416","author":"SC Emencheta","year":"2023","unstructured":"Emencheta SC et al (2023) The role of bacteriophages in the gut microbiota: implications for human health. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15102416","journal-title":"Pharmaceutics"},{"issue":"7","key":"10784_CR48","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41564-021-00928-6","volume":"6","author":"S Nayfach","year":"2021","unstructured":"Nayfach S et al (2021) Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nat Microbiol 6(7):960\u2013970","journal-title":"Nat Microbiol"},{"issue":"10","key":"10784_CR49","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/nm.3950","volume":"21","author":"ES Lim","year":"2015","unstructured":"Lim ES et al (2015) Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med 21(10):1228\u20131234","journal-title":"Nat Med"},{"key":"10784_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1379382","author":"X Yu","year":"2024","unstructured":"Yu X et al (2024) Gut phageome: challenges in research and impact on human microbiota. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2024.1379382","journal-title":"Front Microbiol"},{"key":"10784_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102454","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Gut phageome\u2014an insight into the role and impact of gut microbiome and their correlation with mammal health and diseases. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms11102454","journal-title":"Microorganisms"},{"issue":"7","key":"10784_CR52","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/gutjnl-2018-318131","volume":"68","author":"T Zuo","year":"2019","unstructured":"Zuo T et al (2019) Gut mucosal virome alterations in ulcerative colitis. Gut 68(7):1169\u20131179","journal-title":"Gut"},{"issue":"9","key":"10784_CR53","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1002\/jcp.28333","volume":"234","author":"A Salek Farrokhi","year":"2019","unstructured":"Salek Farrokhi A et al (2019) Is it true that gut microbiota is considered as panacea in cancer therapy? J Cell Physiol 234(9):14941\u201314950","journal-title":"J Cell Physiol"},{"issue":"8","key":"10784_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00535-022-01882-8","volume":"57","author":"T Imai","year":"2022","unstructured":"Imai T et al (2022) Features of the gut prokaryotic virome of Japanese patients with Crohn\u2019s disease. J Gastroenterol 57(8):559\u2013570","journal-title":"J Gastroenterol"},{"issue":"1","key":"10784_CR55","doi-asserted-by":"publisher","first-page":"26875","DOI":"10.1038\/s41598-025-12299-7","volume":"15","author":"S Nechat","year":"2025","unstructured":"Nechat S et al (2025) An epithelial cell culture model for sturgeon integument responds sensitively to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Sci Rep 15(1):26875","journal-title":"Sci Rep"},{"issue":"2","key":"10784_CR56","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee M, Chang EB (2021) Inflammatory bowel diseases (IBD) and the microbiome\u2014searching the crime scene for clues. Gastroenterology 160(2):524\u2013537","journal-title":"Gastroenterology"},{"issue":"4","key":"10784_CR57","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","volume":"152","author":"SJ Ott","year":"2017","unstructured":"Ott SJ et al (2017) Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology 152(4):799\u2013811","journal-title":"Gastroenterology"},{"issue":"3","key":"10784_CR58","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41396-021-01107-5","volume":"16","author":"A Brunse","year":"2022","unstructured":"Brunse A et al (2022) Fecal filtrate transplantation protects against necrotizing enterocolitis. ISME J 16(3):686\u2013694","journal-title":"ISME J"},{"issue":"12","key":"10784_CR59","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1136\/gutjnl-2019-320005","volume":"69","author":"TS Rasmussen","year":"2020","unstructured":"Rasmussen TS et al (2020) Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model. Gut 69(12):2122\u20132130","journal-title":"Gut"},{"key":"10784_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1050895","author":"C Chen","year":"2023","unstructured":"Chen C et al (2023) Alterations of the gut virome in patients with systemic lupus erythematosus. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1050895","journal-title":"Front Immunol"},{"issue":"1","key":"10784_CR61","doi-asserted-by":"publisher","first-page":"21658","DOI":"10.1038\/s41598-022-25979-5","volume":"12","author":"P Villoslada-Blanco","year":"2022","unstructured":"Villoslada-Blanco P et al (2022) Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome. Sci Rep 12(1):21658","journal-title":"Sci Rep"},{"issue":"1","key":"10784_CR62","doi-asserted-by":"publisher","first-page":"2107866","DOI":"10.1080\/19490976.2022.2107866","volume":"14","author":"A Boix-Amor\u00f3s","year":"2022","unstructured":"Boix-Amor\u00f3s A et al (2022) Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease. Gut Microbes 14(1):2107866","journal-title":"Gut Microbes"},{"issue":"23","key":"10784_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells13231987","volume":"13","author":"MA Hemmati","year":"2024","unstructured":"Hemmati MA et al (2024) Using new technologies to analyze gut microbiota and predict cancer risk. Cells 13(23):1987","journal-title":"Cells"},{"issue":"2","key":"10784_CR64","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.tim.2021.04.007","volume":"30","author":"M Khan Mirzaei","year":"2022","unstructured":"Khan Mirzaei M, Deng L (2022) New technologies for developing phage-based tools to manipulate the human microbiome. Trends Microbiol 30(2):131\u2013142","journal-title":"Trends Microbiol"},{"issue":"1","key":"10784_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100383","volume":"3","author":"G Zampieri","year":"2023","unstructured":"Zampieri G et al (2023) Metatranscriptomics-guided genome-scale metabolic modeling of microbial communities. Cell Rep Methods 3(1):100383","journal-title":"Cell Rep Methods"},{"issue":"3","key":"10784_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae117","volume":"25","author":"W Nie","year":"2024","unstructured":"Nie W et al (2024) Advances in phage\u2013host interaction prediction: in silico method enhances the development of phage therapies. Brief Bioinform 25(3):bbae117","journal-title":"Brief Bioinform"},{"issue":"11","key":"10784_CR67","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41564-024-01832-5","volume":"9","author":"B Gaborieau","year":"2024","unstructured":"Gaborieau B et al (2024) Prediction of strain level phage-host interactions across the Escherichia genus using only genomic information. Nat Microbiol 9(11):2847\u20132861","journal-title":"Nat Microbiol"},{"issue":"1","key":"10784_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12551-023-01124-y","volume":"16","author":"M Hosokawa","year":"2024","unstructured":"Hosokawa M, Nishikawa Y (2024) Tools for microbial single-cell genomics for obtaining uncultured microbial genomes. Biophys Rev 16(1):69\u201377","journal-title":"Biophys Rev"},{"issue":"5","key":"10784_CR69","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.chom.2020.08.003","volume":"28","author":"AC Gregory","year":"2020","unstructured":"Gregory AC et al (2020) The gut virome database reveals age-dependent patterns of virome diversity in the human gut. Cell Host Microbe 28(5):724\u2013740","journal-title":"Cell Host Microbe"},{"key":"10784_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1078760","author":"KE Schackart","year":"2023","unstructured":"Schackart KE et al (2023) Evaluation of computational phage detection tools for metagenomic datasets. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2023.1078760","journal-title":"Front Microbiol"},{"issue":"4","key":"10784_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002083","volume":"21","author":"S Roux","year":"2023","unstructured":"Roux S et al (2023) iPHoP: an integrated machine learning framework to maximize host prediction for metagenome-derived viruses of archaea and bacteria. PLoS Biol 21(4):e3002083","journal-title":"PLoS Biol"},{"issue":"2","key":"10784_CR72","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/femsre\/fuv048","volume":"40","author":"RA Edwards","year":"2016","unstructured":"Edwards RA et al (2016) Computational approaches to predict bacteriophage\u2013host relationships. FEMS Microbiol Rev 40(2):258\u2013272","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"10784_CR73","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt.3011","volume":"32","author":"RJ Citorik","year":"2014","unstructured":"Citorik RJ, Mimee M, Lu TK (2014) Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 32(11):1141\u20131145","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10784_CR74","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.chempr.2024.06.004","volume":"10","author":"Y-K Qi","year":"2024","unstructured":"Qi Y-K, Zheng J-S, Liu L (2024) Mirror-image protein and peptide drug discovery through mirror-image phage display. Chem 10(8):2390\u20132407","journal-title":"Chem"},{"issue":"1","key":"10784_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/synbio\/ysy002","volume":"3","author":"M Rustad","year":"2018","unstructured":"Rustad M et al (2018) Cell-free TXTL synthesis of infectious bacteriophage T4 in a single test tube reaction. Synth Biol 3(1):ysy002","journal-title":"Synth Biol"},{"key":"10784_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.copbio.2020.11.003","volume":"68","author":"BR Lenneman","year":"2021","unstructured":"Lenneman BR et al (2021) Enhancing phage therapy through synthetic biology and genome engineering. Curr Opin Biotechnol 68:151\u2013159","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"10784_CR77","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4049\/jimmunol.2300480","volume":"212","author":"K Han","year":"2024","unstructured":"Han K et al (2024) Engineering strategies to modulate the gut microbiome and immune system. J Immunol 212(2):208\u2013215","journal-title":"J Immunol"},{"key":"10784_CR78","doi-asserted-by":"publisher","unstructured":"Mani I (2023) Chapter seven - phage and phage cocktails formulations. In: Singh V (ed) Progress in molecular biology and translational science, vol\u00a0200. Academic Press, pp 159\u2013169.\u00a0https:\/\/doi.org\/10.1016\/bs.pmbts.2023.04.007","DOI":"10.1016\/bs.pmbts.2023.04.007"},{"issue":"9","key":"10784_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8091420","volume":"8","author":"B Guti\u00e9rrez","year":"2020","unstructured":"Guti\u00e9rrez B, Domingo-Calap P (2020) Phage therapy in gastrointestinal diseases. Microorganisms 8(9):1420","journal-title":"Microorganisms"},{"issue":"4","key":"10784_CR80","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.tim.2018.10.008","volume":"27","author":"R Monteiro","year":"2019","unstructured":"Monteiro R et al (2019) Phage therapy: going temperate? Trends Microbiol 27(4):368\u2013378","journal-title":"Trends Microbiol"},{"issue":"7","key":"10784_CR81","first-page":"840","volume":"11","author":"M Galtier","year":"2017","unstructured":"Galtier M et al (2017) Bacteriophages targeting adherent invasive escherichia coli strains as a promising new treatment for Crohn\u2019s disease. J Crohns Colitis 11(7):840\u2013847","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10784_CR82","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1128\/AAC.01774-15","volume":"60","author":"JY Nale","year":"2016","unstructured":"Nale JY et al (2016) Bacteriophage combinations significantly reduce Clostridium difficile growth in vitro and proliferation in vivo. Antimicrob Agents Chemother 60(2):968\u2013981","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10784_CR83","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/cells9041013","volume":"9","author":"M Maronek","year":"2020","unstructured":"Maronek M et al (2020) Phages and their role in gastrointestinal disease: focus on inflammatory bowel disease. Cells 9(4):1013","journal-title":"Cells"},{"key":"10784_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2023.109923","volume":"288","author":"L Li","year":"2024","unstructured":"Li L et al (2024) Oral phages prophylaxis against mixed Escherichia coli O157:H7 and Salmonella Typhimurium infections in weaned piglets. Vet Microbiol 288:109923","journal-title":"Vet Microbiol"},{"issue":"1","key":"10784_CR85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12917-023-03724-y","volume":"19","author":"X Mao","year":"2023","unstructured":"Mao X et al (2023) Oral phage therapy with microencapsulated phage A221 against Escherichia coli infections in weaned piglets. BMC Vet Res 19(1):165","journal-title":"BMC Vet Res"},{"key":"10784_CR86","doi-asserted-by":"publisher","first-page":"1432703","DOI":"10.3389\/fmed.2024.1432703","volume":"11","author":"J Qu","year":"2024","unstructured":"Qu J et al (2024) Phage therapy of extensively drug resistant Acinetobacter baumannii infections: evaluating the distribution of phage in human body and the impact on gut microbiome 11:1432703. https:\/\/doi.org\/10.3389\/fmed.2024.1432703","journal-title":"Phage therapy of extensively drug resistant Acinetobacter baumannii infections: evaluating the distribution of phage in human body and the impact on gut microbiome"},{"issue":"2","key":"10784_CR87","first-page":"e60127","volume":"11","author":"SN Peerayeh","year":"2016","unstructured":"Peerayeh SN et al (2016) High frequency of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates from male patients\u2019 urine 11(2):e60127","journal-title":"High frequency of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates from male patients' urine"},{"issue":"5","key":"10784_CR88","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick RM et al (2019) Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 25(5):730\u2013733","journal-title":"Nat Med"},{"issue":"5","key":"10784_CR89","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jgg.2024.01.002","volume":"51","author":"L Zheng","year":"2024","unstructured":"Zheng L et al (2024) Genome engineering of the human gut microbiome. J Genet Genomics 51(5):479\u2013491","journal-title":"J Genet Genomics"},{"issue":"6","key":"10784_CR90","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/idr16060092","volume":"16","author":"M Palma","year":"2024","unstructured":"Palma M, Qi B (2024) Advancing phage therapy: a comprehensive review of the safety, efficacy, and future prospects for the targeted treatment of bacterial infections. Infect Dis Rep 16(6):1127\u20131181","journal-title":"Infect Dis Rep"},{"issue":"13","key":"10784_CR91","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.7150\/ijbs.60551","volume":"17","author":"X Li","year":"2021","unstructured":"Li X et al (2021) A combination therapy of phages and antibiotics: two is better than one. Int J Biol Sci 17(13):3573\u20133582","journal-title":"Int J Biol Sci"},{"key":"10784_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2021.100887","volume":"42","author":"M Karbalaei","year":"2021","unstructured":"Karbalaei M et al (2021) Alleviation of halitosis by use of probiotics and their protective mechanisms in the oral cavity. New Microbes New Infect 42:100887","journal-title":"New Microbes New Infect"},{"key":"10784_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109545","volume":"114","author":"C Dai","year":"2023","unstructured":"Dai C, Huang Y-H, Jiang M (2023) Combination therapy in inflammatory bowel disease: current evidence and perspectives. Int Immunopharmacol 114:109545","journal-title":"Int Immunopharmacol"},{"key":"10784_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6040086","author":"A Paule","year":"2018","unstructured":"Paule A, Frezza D, Edeas M (2018) Microbiota and phage therapy: future challenges in medicine. Med Sci. https:\/\/doi.org\/10.3390\/medsci6040086","journal-title":"Med Sci"},{"issue":"3","key":"10784_CR95","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/antibiotics8030131","volume":"8","author":"S Divya Ganeshan","year":"2019","unstructured":"Divya Ganeshan S, Hosseinidoust Z (2019) Phage therapy with a focus on the human microbiota. Antibiotics 8(3):131","journal-title":"Antibiotics"},{"issue":"2","key":"10784_CR96","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/microorganisms13020295","volume":"13","author":"M Eslami","year":"2025","unstructured":"Eslami M et al (2025) Innovative antibiotic therapies for carbapenem-resistant gram-negative bacterial infections: clinical efficacy, safety, and comparative studies. Microorganisms 13(2):295","journal-title":"Microorganisms"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10784-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10784-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10784-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:05:19Z","timestamp":1778753119000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10784-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10784"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10784-z","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was done via observation. There is no need for ethical approval for the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"\u201cNot applicable\u201d for studies not involving humans or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"\u201cNot applicable\u201d for studies not involving humans.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}